Search Ontology:
ChEBI
medroxyprogesterone acetate
- Term ID
- CHEBI:6716
- Synonyms
-
- (6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
- (6alpha)-6-methyl-3,20-dioxopregn-4-en-17-yl acetate
- 17-Acetoxy-6alpha-methylprogesterone
- 17alpha-Hydroxy-6alpha-methylprogesterone acetate
- 6-alpha-Methyl-17-alpha-acetoxyprogesterone
- 6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate
- 6alpha-Methyl-17-acetoxy progesterone
- 6alpha-Methyl-17alpha-hydroxyprogesterone acetate
- 6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate
- CBP-1011
- Depo-Provera
- depot medroxyprogesterone acetate
- DMPA
- MAP
- Medroxyacetate progesterone
- Medroxyprogesterone 17-acetate
- Medroxyprogesterone acetate
- Methylacetoxyprogesterone
- Metigestrona
- Definition
- An acetate ester resulting from the formal condensation of the 17alpha-hydroxy group of medroxyprogesterone with the carboxy group of acetic acid. A widely used progestin in menopausal hormone therapy and in progestogen-only birth control.
- References
-
- Beilstein:2066112
- CAS:71-58-9
- Chemspider:4642461
- DrugBank:DB00603
- Drug_Central:1659
- KEGG:C08150
- KEGG:D00951
- PMID:11156860
- PMID:11925144
- PMID:15973592
- PMID:16645869
- PMID:18497975
- PMID:18541028
- PMID:19017820
- PMID:19181558
- PMID:20173089
- PMID:29386945
- PMID:29393479
- PMID:29694506
- PMID:30452655
- PMID:30585733
- PMID:30633132
- PMID:30721635
- PMID:30741807
- PMID:30866773
- PMID:30894394
- PMID:30927417
- PMID:31019626
- PMID:31077968
- PMID:31127826
- PMID:31171559
- PMID:31228485
- PMID:31403601
- PMID:31421164
- PMID:31479152
- PMID:31491645
- PMID:31504342
- PMID:31537512
- PMID:31635772
- PMID:31718641
- PMID:31732107
- PMID:31805393
- PMID:31838718
- PMID:31928370
- PMID:31935387
- PMID:7502690
- Wikipedia:Medroxyprogesterone_acetate
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_functional_parent
-
- has_role
Phenotype
Phenotype resulting from medroxyprogesterone acetate
Phenotype where environments contain medroxyprogesterone acetate
Phenotype modified by environments containing medroxyprogesterone acetate
Human Disease Model